Healthcare Sector

BPMC

Market Tracker

  • BPMC (Selected)

    Blueprint Medicines Corporation

BPMC Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BPMC Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BPMC Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BPMC Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
06/20/2025 PUT $125.00 1,420 +14 +1.00%
07/18/2025 CALL $130.00 75 +10 +15.38%
01/16/2026 CALL $125.00 38 +10 +35.71%
10/17/2025 CALL $120.00 11 +3 +37.50%
12/19/2025 CALL $125.00 5 +3 +150.00%
12/19/2025 CALL $120.00 69 +2 +2.99%
01/16/2026 PUT $125.00 1,145 0
01/16/2026 PUT $130.00 30 0
01/16/2026 PUT $135.00 0 0
01/16/2026 PUT $140.00 0 0
01/16/2026 PUT $145.00 0 0
07/18/2025 PUT $125.00 140 -1 -0.71%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BPMC Major Holders

Name Pct Held Shares Total
Vanguard Specialized-Health Care Fund 3.97% 2.38M 141.75M
Vanguard Total Stock Market Index Fund 3.02% 1.81M 107.84M
Price (T.Rowe) New Horizons Fund 2.82% 1.69M 100.69M
Vanguard Small-Cap Index Fund 2.57% 1.54M 91.84M
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 2.42% 1.45M 86.35M
iShares Russell 2000 ETF 2.19% 1.32M 78.42M
Fidelity Advisor Biotechnology Fund 2.16% 1.3M 77.16M
Fidelity Select Portfolios - Biotechnology 2.09% 1.25M 74.74M
Price (T.Rowe) Health Sciences Fund 1.87% 1.12M 66.91M
Fidelity Select Portfolios - Health Care 1.67% 1M 59.58M

BPMC News

  • Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta

    06/06 03:37 pm

    Benzinga

    Read more
  • Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout

    06/02 08:12 am

    Benzinga

    Read more
  • NUT Midline Carcinoma Treatment Market Research Report 2023-2024 & 2034: Market Forecast by Treatment, Route of Administration, and End-User Across 5 Regions and 17+ Countries

    01/09 11:53 am

    GlobeNewswire Inc.

    Read more
  • Expert Ratings For Blueprint Medicines

    06/28 09:00 am

    Benzinga

    Read more
  • Assessing Blueprint Medicines: Insights From 16 Financial Analysts

    06/07 02:01 pm

    Benzinga

    Read more
  • Unveiling 18 Analyst Insights On Blueprint Medicines

    05/14 12:00 pm

    Benzinga

    Read more
  • Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand

    05/07 06:40 am

    Zacks Investment Research

    Read more
  • PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?

    05/06 01:00 pm

    Zacks Investment Research

    Read more
  • 5 Biotech Stocks Worth Adding to Your Portfolio in 2024

    05/06 09:50 am

    Zacks Investment Research

    Read more
  • Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises

    05/03 09:51 am

    Zacks Investment Research

    Read more
  • Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates

    05/02 12:32 pm

    Zacks Investment Research

    Read more
  • Blueprint Medicines (BPMC) Reports Q1 Loss, Tops Revenue Estimates

    05/02 08:10 am

    Zacks Investment Research

    Read more
  • Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings

    05/01 01:04 pm

    Zacks Investment Research

    Read more
  • Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?

    05/01 11:03 am

    Zacks Investment Research

    Read more
  • What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?

    04/30 12:22 pm

    Zacks Investment Research

    Read more
  • Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know

    04/30 10:00 am

    Zacks Investment Research

    Read more
  • Sustained Product Demand Likely to Aid BD's (BDX) Q2 Earnings

    04/29 12:21 pm

    Zacks Investment Research

    Read more
  • Factors Setting the Tone for Ecolab's (ECL) Q1 Earnings

    04/26 01:10 pm

    Zacks Investment Research

    Read more
  • The Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Experts

    04/26 08:00 am

    Benzinga

    Read more
  • Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

    04/25 10:01 am

    Zacks Investment Research

    Read more
  • Decoding 6 Analyst Evaluations For Blueprint Medicines

    04/10 03:00 pm

    Benzinga

    Read more
  • CRISPR Therapeutics (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?

    03/22 11:30 am

    Zacks Investment Research

    Read more
  • Why Is Halozyme Therapeutics (HALO) Up 5.3% Since Last Earnings Report?

    03/21 11:30 am

    Zacks Investment Research

    Read more
  • Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?

    03/12 08:03 am

    Zacks Investment Research

    Read more
  • Here's What Key Metrics Tell Us About Blueprint Medicines (BPMC) Q4 Earnings

    02/16 04:30 pm

    Zacks Investment Research

    Read more
  • Blueprint (BPMC) Q4 Earnings Beat, Stock Up as Ayvakit Shines

    02/16 06:47 am

    Zacks Investment Research

    Read more
  • Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday

    02/15 11:23 am

    Benzinga

    Read more
  • Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates

    02/15 09:25 am

    Zacks Investment Research

    Read more
  • Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More

    02/14 11:12 am

    Zacks Investment Research

    Read more
  • Apellis Pharmaceuticals, Inc. (APLS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

    02/13 11:00 am

    Zacks Investment Research

    Read more
  • Cracking The Code: Understanding Analyst Reviews For Blueprint Medicines

    02/13 11:00 am

    Benzinga

    Read more
  • Seeking Clues to Blueprint Medicines (BPMC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

    02/12 10:16 am

    Zacks Investment Research

    Read more
  • Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

    02/08 11:00 am

    Zacks Investment Research

    Read more
  • Vertex (VRTX) to Report Q4 Earnings: What's in the Cards?

    02/02 11:47 am

    Zacks Investment Research

    Read more
  • Gilead (GILD) Gears Up to Report Q4 Earnings: Whats in Store?

    02/02 09:28 am

    Zacks Investment Research

    Read more
  • What Makes Blueprint Medicines (BPMC) a New Buy Stock

    01/16 01:00 pm

    Zacks Investment Research

    Read more
  • Reasons to Add Blueprint (BPMC) Stock to Your Portfolio Now

    01/16 12:51 pm

    Zacks Investment Research

    Read more
  • Peeling Back The Layers: Exploring Blueprint Medicines Through Analyst Insights

    01/09 11:00 am

    Benzinga

    Read more
  • Biotech stocks set for a rebound in 2024, analysts say

    12/23 07:50 am

    MarketWatch

    Read more
  • Raymond James Maintains Strong Buy Rating for Blueprint Medicines: Here's What You Need To Know

    12/22 01:00 pm

    Benzinga

    Read more
  • Blueprint (BPMC) Gets EC Nod for Ayvakit Expanded Use, Stock Up

    12/13 01:56 pm

    Zacks Investment Research

    Read more
  • Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session

    12/11 02:12 pm

    Benzinga

    Read more
  • The Latest Analyst Ratings for Blueprint Medicines

    12/11 08:00 am

    Benzinga

    Read more
  • Why Is Gilead (GILD) Up 1.9% Since Last Earnings Report?

    12/07 12:30 pm

    Zacks Investment Research

    Read more
  • Why Is Axsome (AXSM) Up 8.7% Since Last Earnings Report?

    12/06 12:30 pm

    Zacks Investment Research

    Read more
  • Why Is Glaxo (GSK) Up 5.3% Since Last Earnings Report?

    12/01 12:32 pm

    Zacks Investment Research

    Read more
  • Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue?

    11/30 12:31 pm

    Zacks Investment Research

    Read more
  • Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 1.7% Since Last Earnings Report?

    11/29 12:30 pm

    Zacks Investment Research

    Read more
  • Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?

    11/16 10:40 am

    Zacks Investment Research

    Read more
  • How Much Upside is Left in Blueprint Medicines (BPMC)? Wall Street Analysts Think 42.16%

    10/31 09:55 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: